News Healthy Blood Donors Needed Near Philadelphia, PA Sep 3, 2026 Read More → G-CSF and Plerixafor (PLX) Mobilization Regimens: An 18-Month Retrospective Analysis of TNC Yield and CD34+/CD15+ Cellular Composition in Mobilized Leukopaks Aug 27, 2026 Read More → From Sample to Signal: How Biospecimen Quality Impacts Multiomic Assay Development Jul 23, 2026 Read More → The Infrastructure Behind Allogeneic Cell Therapy: Why Donor Programs Matter More Than Ever Jun 15, 2026 Read More → CGT Global Appoints Charlotte Ivancic to Board of Advisors, Strengthening Strategic Leadership in Cell and Gene Therapy Policy and Market Access May 21, 2026 Read More → Leukopak vs PBMC vs Whole Blood: What’s the Difference and Which One Do You Need? May 14, 2026 Read More → T Cell Activation in Cell Therapy: Why T Cell Activation Fails Without the Right Starting Material Apr 17, 2026 Read More → Why CGT Global Is Positioned to Support the Next Wave of Cell and Gene Therapies Mar 5, 2026 Read More → Bulk CD34+ Isolation from Mobilized Leukopaks: GCSF vs GCSF + PLX vs PLX Feb 24, 2026 Read More →
